Product Information
TRIAMTERENE 50 MG CAPSULE is a generic product labeled by Prasco Laboratories, priced at $5.9753 per EA under NDC 66993083102. Its NADAC has been published 181 times since Sep 22, 2021.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Prasco LaboratoriesNDC
66993083102
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
TRIAMTERENEApproval Type
Authorized Generic (NDA)
FDA Application
NDA013174FDA Approved
Before 1982
TE Code
AB
On Market Since
8/13/2019
Pharmacological Classes
Price Statistics
The NADAC for TRIAMTERENE 50 MG CAPSULE has been published 181 times since Sep 22, 2021, and over the history we have for it it has declined 31.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.9753 per EA |
|---|---|
| All-time high | $8.7204 (Sep 14, 2022) |
| All-time low | $5.9753 (Sep 23, 2026) |
| 52-week high | $7.4785 |
| 52-week low | $5.9753 |
| Median price | $6.9288 |
| Average price | $7.2658 |
| Largest weekly change | -20.8% (Apr 17, 2024) |
| Weeks tracked | 181 |
| Tracking since | Sep 22, 2021 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Prasco Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Triamterene market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Potassium-sparing Diuretic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TRIAMTERENE 50 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TRIAMTERENE 50 MG CAPSULE, manufactured by Prasco Laboratories, is $5.9753 per EA (NDC 66993083102), effective Sep 30, 2026.
How has the price of TRIAMTERENE 50 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TRIAMTERENE 50 MG CAPSULE has declined 31.5%. It has been tracked across 181 weekly CMS publications since Sep 22, 2021.
What are the highest and lowest recorded NADAC prices for TRIAMTERENE 50 MG CAPSULE?
Since Sep 22, 2021, the NADAC for TRIAMTERENE 50 MG CAPSULE has ranged from a low of $5.9753 (Sep 23, 2026) to a high of $8.7204 (Sep 14, 2022), with a median of $6.9288 per EA.
Are there cheaper alternatives to TRIAMTERENE 50 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TRIAMTERENE 50 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures TRIAMTERENE 50 MG CAPSULE?
TRIAMTERENE 50 MG CAPSULE (NDC 66993083102) is labeled by Prasco Laboratories, and CMS classifies it as a generic product.